Inivata's John Beeler on the future of liquid biopsies

John Beeler, VP of corporate and business development at Inivata, speaks to Scrip's Lucie Ellis about how the company's technology is aligned with the current genomic medicine revolution in pharma. At BIO-Europe® in Berlin, Beeler talks about the company's emerging liquid tissue biopsy technology and how it can be applied to drug development through collaborations with pharma and biotech partners.